SLG
XLRN

Stanley-Laman Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Stanley-Laman Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-125,020
Closed -$7.16M – 307
2018
Q3 		$7.16M Buy
+125,020
New +$7.16M 1.76% 6